Literature DB >> 31451216

Sulfur metabolism and its contribution to malignancy.

Nathan P Ward1, Gina M DeNicola2.   

Abstract

Metabolic dysregulation is an appreciated hallmark of cancer and a target for therapeutic intervention. Cellular metabolism involves a series of oxidation/reduction (redox) reactions that yield the energy and biomass required for tumor growth. Cells require diverse molecular species with constituent sulfur atoms to facilitate these processes. For humans, this sulfur is derived from the dietary consumption of the proteinogenic amino acids cysteine and methionine, as only lower organisms (e.g., bacteria, fungi, and plants) can synthesize them de novo. In addition to providing the sulfur required to sustain redox chemistry, the metabolism of these sulfur-containing amino acids yield intermediate metabolites that constitute the cellular antioxidant system, mediate inter- and intracellular signaling, and facilitate the epigenetic regulation of gene expression, all of which contribute to tumorigenesis.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer metabolism; Cysteine; Glutathione; Hydrogen sulfide; Methionine; S-Adenosylmethionine; Sulfur

Mesh:

Substances:

Year:  2019        PMID: 31451216     DOI: 10.1016/bs.ircmb.2019.05.001

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  10 in total

Review 1.  Volatile Organic Compounds Analysis as a Potential Novel Screening Tool for Breast Cancer: A Systematic Review.

Authors:  Michelle Leemans; Pierre Bauër; Vincent Cuzuel; Etienne Audureau; Isabelle Fromantin
Journal:  Biomark Insights       Date:  2022-05-23

Review 2.  Chemistry and Biochemistry of Sulfur Natural Compounds: Key Intermediates of Metabolism and Redox Biology.

Authors:  Antonio Francioso; Alessia Baseggio Conrado; Luciana Mosca; Mario Fontana
Journal:  Oxid Med Cell Longev       Date:  2020-09-29       Impact factor: 6.543

3.  Plasma metabolomic profile associated with fatigue in cancer patients.

Authors:  Li Rebekah Feng; Jennifer J Barb; Jeniece Regan; Leorey N Saligan
Journal:  Cancer Med       Date:  2021-02-03       Impact factor: 4.452

Review 4.  Hydrogen Sulfide, an Endogenous Stimulator of Mitochondrial Function in Cancer Cells.

Authors:  Csaba Szabo
Journal:  Cells       Date:  2021-01-22       Impact factor: 6.600

5.  Identification of a Four-Gene Signature for Determining the Prognosis of Papillary Thyroid Carcinoma by Integrated Bioinformatics Analysis.

Authors:  Yuting Luo; Rong Chen; Zhikun Ning; Nantao Fu; Minghao Xie
Journal:  Int J Gen Med       Date:  2022-02-04

Review 6.  Thiophenes-Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors.

Authors:  Sabrin R M Ibrahim; Abdelsattar M Omar; Alaa A Bagalagel; Reem M Diri; Ahmad O Noor; Diena M Almasri; Shaimaa G A Mohamed; Gamal A Mohamed
Journal:  Plants (Basel)       Date:  2022-02-17

7.  The clinical outcome and risk factors analysis of immune checkpoint inhibitor-based treatment in lung adenocarcinoma patients with brain metastases.

Authors:  Juan Zhou; Yinfei Wu; Mengqing Xie; Yujia Fang; Jing Zhao; Sung Yong Lee; Yunjoo Im; Lingyun Ye; Chunxia Su
Journal:  Transl Lung Cancer Res       Date:  2022-04

8.  m6A-related metabolism molecular classification with distinct prognosis and immunotherapy response in soft tissue sarcoma.

Authors:  Zhen-Dong Huang; Yong-Cheng Fu; Shu-Yan Liu; Ya-Juan Mao; Yan Zhang; Chao Hu; Ren-Xiong Wei
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

9.  Identifying cancer tissue-of-origin by a novel machine learning method based on expression quantitative trait loci.

Authors:  Yongchang Miao; Xueliang Zhang; Sijie Chen; Wenjing Zhou; Dalai Xu; Xiaoli Shi; Jian Li; Jinhui Tu; Xuelian Yuan; Kebo Lv; Geng Tian
Journal:  Front Oncol       Date:  2022-08-09       Impact factor: 5.738

10.  Response to sulfur in Schizosaccharomyces pombe.

Authors:  Hokuto Ohtsuka; Takafumi Shimasaki; Hirofumi Aiba
Journal:  FEMS Yeast Res       Date:  2021-07-24       Impact factor: 2.796

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.